南新制药: 2024年年度股东大会决议公告

Meeting Overview - The shareholders' meeting of Hunan Nanxin Pharmaceutical Co., Ltd. was held on June 13, 2025, in Guangzhou, Guangdong Province [1]. - The meeting was presided over by Chairman Zhang Shixi and utilized a combination of on-site and online voting methods [1]. Attendance and Voting - A total of 56 ordinary shareholders attended the meeting, holding 80,977,423 voting rights, which represents 29.6961% of the company's total voting rights [1]. - The voting results showed a strong majority in favor of the proposals, with ordinary shareholders voting 98.1570% in favor of the first resolution [2]. Resolutions Passed - Multiple resolutions were passed during the meeting, including: - The proposal for the company to provide guarantees for its subsidiaries [3]. - The profit distribution proposal for the year 2024 [3]. - The proposal to purchase directors and supervisors' liability insurance [3]. - The proposal to cancel a subsidiary [3]. - The proposal to use excess raised funds to permanently supplement working capital [3]. Legal Compliance - The meeting's procedures, including the qualifications of attendees and the voting process, were confirmed to be in compliance with legal regulations and the company's articles of association [3].